These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30835587)

  • 1. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye.
    Li J; Cheng T; Tian Q; Cheng Y; Zhao L; Zhang X; Qu Y
    Drug Deliv; 2019 Dec; 26(1):188-198. PubMed ID: 30835587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
    Cheng T; Li J; Cheng Y; Zhang X; Qu Y
    Exp Eye Res; 2019 Nov; 188():107805. PubMed ID: 31526807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.
    Kambhampati SP; Mishra MK; Mastorakos P; Oh Y; Lutty GA; Kannan RM
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):239-49. PubMed ID: 25701805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation.
    Raval N; Khunt D; Misra M
    J Microencapsul; 2018 Jan; 35(1):62-77. PubMed ID: 29307286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration.
    Hirani A; Grover A; Lee YW; Pathak Y; Sutariya V
    Pharm Dev Technol; 2016; 21(1):61-7. PubMed ID: 25259682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
    Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
    Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear, Aqueous Topical Drop of Triamcinolone Acetonide.
    Trinh HM; Cholkar K; Joseph M; Yang X; Mitra AK
    AAPS PharmSciTech; 2017 Oct; 18(7):2466-2478. PubMed ID: 28185211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
    Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
    Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular sustained-release delivery systems for triamcinolone acetonide.
    Mansoor S; Kuppermann BD; Kenney MC
    Pharm Res; 2009 Apr; 26(4):770-84. PubMed ID: 19184374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye.
    Santer V; Chen Y; Kalia YN
    Eur J Pharm Biopharm; 2018 Nov; 132():157-167. PubMed ID: 30266666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery.
    Altamirano-Vallejo JC; Navarro-Partida J; Gonzalez-De la Rosa A; Hsiao JH; Olguín-Gutierrez JS; Gonzalez-Villegas AC; Keller BC; Bouzo-Lopez L; Santos A
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):416-425. PubMed ID: 29584529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies.
    Kapadia R; Parikh K; Jain M; Sawant K
    Drug Deliv Transl Res; 2021 Jun; 11(3):984-999. PubMed ID: 32567039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: A potential topical treatment for posterior segment diseases.
    Khalil M; Hashmi U; Riaz R; Rukh Abbas S
    Int J Biol Macromol; 2020 Jan; 143():483-491. PubMed ID: 31759018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved release of triamcinolone acetonide from medicated soft contact lenses loaded with drug nanosuspensions.
    García-Millán E; Quintáns-Carballo M; Otero-Espinar FJ
    Int J Pharm; 2017 Jun; 525(1):226-236. PubMed ID: 28412447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triamcinolone-loaded self nano-emulsifying drug delivery systems for ocular use: An alternative to invasive ocular surgeries and injections.
    Dehghani M; Zahir-Jouzdani F; Shahbaz S; Andarzbakhsh K; Dinarvand S; Fathian Nasab MH; Asadi Amoli F; Asgharian R; Atyabi F
    Int J Pharm; 2024 Mar; 653():123840. PubMed ID: 38262585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.
    Korodi T; Lachmann B; Kopelent-Frank H
    Pharmazie; 2010 Dec; 65(12):860-6. PubMed ID: 21284253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes.
    Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y
    Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-invasive nanoparticle-based sustained dual-drug delivery system as an eyedrop for endophthalmitis.
    Mahaling B; Baruah N; Ahamad N; Maisha N; Lavik E; Katti DS
    Int J Pharm; 2021 Sep; 606():120900. PubMed ID: 34293472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.